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From the Managing Editor
A Call to Forward-Thinking Bioethics
Heather G. Kuruvilla, Ph.D.
Cedarville University

It is said that hindsight is always 20/20. However, a reasoned approach to practical bioethics requires an
awareness of developing technologies and their potential applications to clinical practice. As a recent
example, the powerful gene editing technology, CRISPR/Cas 9 has been widely used in the laboratory
both to repair genetic defects and to disrupt gene expression. When Liang et al. 1 published their study on
April 18, which used CRISPR to edit non-viable human zygotes, a firestorm of debate ensued.
The data obtained by Liang et al. indicate a low editing efficiency in the embryos, as well as a high
number of off-target mutations. 2 As reported to Nature, one of the scientists in the study, Dr. Huang,
noted, “That’s why we stopped [the research]. It [the technology is] is still too immature.” 3
Other scientists remain convinced that such research on the human germline should not be allowed at
present. For example, Lanphier and his colleagues, who use CRISPR to modify somatic cells, believe
that using CRISPR on germ-line cells could have unpredictable, potentially harmful effects on future
generations of human beings. 4 However, they cite several examples of CRISPR-based somatic cell
therapies in various stages of development, including a treatment for β-thassalemia that is scheduled to
begin phase I trials later this year. 5
While using genetically modified somatic cells certainly raises concerns of safety and efficacy, those
concerns are limited to the individual being treated. Our current protocols for clinical trials are designed
to address such questions. But the possibility of causing heritable genetic damage remains one of the
major reasons that many nations, including the US, ban research that modifies the human germline.
The technical difficulties encountered by Liang and colleagues open up the floor for meaningful
bioethical discussion. Now is the time to address deep issues of what it means to be human. Are
concerns about modifying the human germline simply limited to safety and efficacy? If so, such concerns
will likely be resolved as technology improves. And the technology is likely to improve quickly, as other
scientists continue this research and perfect their protocols. Nature news writer David Cyranoski noted in
his March 18th article that several research teams are nearing publication of work similar to the study
published by Liang et al. 6
However, beyond the safety concerns lie deeper questions. Certainly the ability to edit the genome brings
with it all kinds of therapeutic possibilities. At the same time, there is no reason why someone could not
use this technology to modify the human species, with good or evil intent. Our genetics are an integral
part of what make us human. We now hold tools which would allow modification of the human genome
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on a much faster time frame than we have ever observed in nature. If we believe that modification of the
human genome should be restricted to therapeutic uses, or even banned altogether, now is the time to
frame those arguments. Now is the time for theoreticians and pragmatists to join forces, talk through the
issues, and set policies. Regulations and laws need to be passed before embryonic human lives are
irreversibly impacted.
How does our use of genetic technology impact us as human persons, and as a biological species? The
window for discussion of these issues is closing as the technology continues to progress. It is time to
speak up, or forever hold our peace.
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